Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The absence of ADAMTS13 improves early outcomes in an experimental model of trauma with uncontrolled hemorrhage.

The journal of trauma and acute care surgery·2026

Same author

Wrapping it up: structural basis of ADAMTS-13 global latency.

Journal of thrombosis and haemostasis : JTH·2026

Same author

Toward improved thrombolysis in ischemic stroke: targeting nonfibrin components.

Research and practice in thrombosis and haemostasis·2026

Same author

Establishing reverse chimeric antigen receptor T cells for precise targeting of immunemediated thrombotic thrombocytopenic purpura.

Haematologica·2026

Same author

Kinetics and dynamics of ionized calcium in a porcine major trauma model.

The journal of trauma and acute care surgery·2026

Same author

Determining ADAMTS13 Conformation for the Diagnosis of Immune Thrombotic Thrombocytopenic Purpura and Prediction of Relapse.

Methods in molecular biology (Clifton, N.J.)·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Antiplatelet drugs.

Simon F De Meyer¹, Karen Vanhoorelbeke, Katleen Broos

¹Laboratory for Thrombosis Research, IRC, KU Leuven Campus Kortrijk, Kortrijk, Belgium.

British Journal of Haematology

|June 3, 2008

Summary

This summary is machine-generated.

Antiplatelet therapy is vital for preventing and treating blood clots. This review covers agents targeting platelet adhesion, activation, and aggregation, crucial for managing thromboembolic diseases.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Experiment Videos

Last Updated: Jul 4, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Area of Science:

Cardiovascular Medicine
Hematology
Pharmacology

Background:

Platelets are central to thromboembolic diseases, necessitating antiplatelet therapy for treatment and prophylaxis.
Vascular injury triggers platelet adhesion, activation, and aggregation, forming arterial plugs, but pathological conditions can cause occlusive thrombi leading to myocardial infarction and stroke.

Purpose of the Study:

To review antiplatelet agents targeting the three principal phases of thrombus formation: adhesion, activation amplification, and aggregation.
To discuss novel experimental targets and established clinical strategies for each phase.
To analyze the limitations and potential benefits of each antiplatelet target.

Main Methods:

Literature review of antiplatelet agents and their mechanisms of action.
Analysis of therapeutic strategies targeting platelet adhesion, activation, and aggregation.
Discussion of experimental and clinical data on antiplatelet therapies.

Main Results:

Antiplatelet agents interfere with key stages of thrombus formation.
Various targets exist for modulating platelet adhesion, activation amplification, and aggregation.
Both novel experimental and established clinical strategies are available.

Conclusions:

Understanding the stages of thrombus formation is key to developing effective antiplatelet therapies.
Targeting platelet adhesion, activation, and aggregation offers therapeutic potential for thromboembolic diseases.
Careful consideration of limitations and benefits is essential for optimizing antiplatelet treatment strategies.